img

Global Viral Vaccines Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Viral Vaccines Market Insights, Forecast to 2034

Global Viral Vaccines market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Viral Vaccines industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Viral Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Viral Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL
Segment by Type
Attenuated Vaccine
Inactivated Vaccine

Segment by Application


Hospital
Pharmaceutical Factory
Research Institute
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Viral Vaccines plant distribution, commercial date of Viral Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Viral Vaccines introduction, etc. Viral Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Viral Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Viral Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Viral Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.3 Market by Application
1.3.1 Global Viral Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmaceutical Factory
1.3.4 Research Institute
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Viral Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Viral Vaccines Revenue by Region
2.2.1 Global Viral Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Viral Vaccines Revenue by Region (2018-2024)
2.2.3 Global Viral Vaccines Revenue by Region (2024-2029)
2.2.4 Global Viral Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Viral Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Viral Vaccines Sales by Region
2.4.1 Global Viral Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Viral Vaccines Sales by Region (2018-2024)
2.4.3 Global Viral Vaccines Sales by Region (2024-2029)
2.4.4 Global Viral Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Viral Vaccines Sales by Manufacturers
3.1.1 Global Viral Vaccines Sales by Manufacturers (2018-2024)
3.1.2 Global Viral Vaccines Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Viral Vaccines in 2022
3.2 Global Viral Vaccines Revenue by Manufacturers
3.2.1 Global Viral Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Viral Vaccines Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Viral Vaccines Revenue in 2022
3.3 Global Key Players of Viral Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Viral Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Viral Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Viral Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Viral Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Viral Vaccines Sales by Type
4.1.1 Global Viral Vaccines Historical Sales by Type (2018-2024)
4.1.2 Global Viral Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Viral Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Viral Vaccines Revenue by Type
4.2.1 Global Viral Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Viral Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Viral Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Viral Vaccines Price by Type
4.3.1 Global Viral Vaccines Price by Type (2018-2024)
4.3.2 Global Viral Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Viral Vaccines Sales by Application
5.1.1 Global Viral Vaccines Historical Sales by Application (2018-2024)
5.1.2 Global Viral Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Viral Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Viral Vaccines Revenue by Application
5.2.1 Global Viral Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Viral Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Viral Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Viral Vaccines Price by Application
5.3.1 Global Viral Vaccines Price by Application (2018-2024)
5.3.2 Global Viral Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Viral Vaccines Market Size by Type
6.1.1 US & Canada Viral Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Viral Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Viral Vaccines Market Size by Application
6.2.1 US & Canada Viral Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Viral Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Viral Vaccines Market Size by Country
6.3.1 US & Canada Viral Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Viral Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Viral Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Viral Vaccines Market Size by Type
7.1.1 Europe Viral Vaccines Sales by Type (2018-2029)
7.1.2 Europe Viral Vaccines Revenue by Type (2018-2029)
7.2 Europe Viral Vaccines Market Size by Application
7.2.1 Europe Viral Vaccines Sales by Application (2018-2029)
7.2.2 Europe Viral Vaccines Revenue by Application (2018-2029)
7.3 Europe Viral Vaccines Market Size by Country
7.3.1 Europe Viral Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Viral Vaccines Sales by Country (2018-2029)
7.3.3 Europe Viral Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Viral Vaccines Market Size
8.1.1 China Viral Vaccines Sales (2018-2029)
8.1.2 China Viral Vaccines Revenue (2018-2029)
8.2 China Viral Vaccines Market Size by Application
8.2.1 China Viral Vaccines Sales by Application (2018-2029)
8.2.2 China Viral Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Viral Vaccines Market Size by Type
9.1.1 Asia Viral Vaccines Sales by Type (2018-2029)
9.1.2 Asia Viral Vaccines Revenue by Type (2018-2029)
9.2 Asia Viral Vaccines Market Size by Application
9.2.1 Asia Viral Vaccines Sales by Application (2018-2029)
9.2.2 Asia Viral Vaccines Revenue by Application (2018-2029)
9.3 Asia Viral Vaccines Sales by Region
9.3.1 Asia Viral Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Viral Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Viral Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Viral Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Viral Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Viral Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Viral Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Viral Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Viral Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Viral Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Viral Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Viral Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Viral Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GSK Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Sanofi Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Bayer
11.6.1 Bayer Company Information
11.6.2 Bayer Overview
11.6.3 Bayer Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bayer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Recent Developments
11.7 Zoetis
11.7.1 Zoetis Company Information
11.7.2 Zoetis Overview
11.7.3 Zoetis Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Zoetis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Zoetis Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 AstraZeneca Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Johnson
11.9.1 Johnson Company Information
11.9.2 Johnson Overview
11.9.3 Johnson Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Johnson Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson Recent Developments
11.10 CSL
11.10.1 CSL Company Information
11.10.2 CSL Overview
11.10.3 CSL Viral Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 CSL Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CSL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Viral Vaccines Industry Chain Analysis
12.2 Viral Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Viral Vaccines Production Mode & Process
12.4 Viral Vaccines Sales and Marketing
12.4.1 Viral Vaccines Sales Channels
12.4.2 Viral Vaccines Distributors
12.5 Viral Vaccines Customers
13 Market Dynamics
13.1 Viral Vaccines Industry Trends
13.2 Viral Vaccines Market Drivers
13.3 Viral Vaccines Market Challenges
13.4 Viral Vaccines Market Restraints
14 Key Findings in The Global Viral Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Viral Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Attenuated Vaccine
Table 3. Major Manufacturers of Inactivated Vaccine
Table 4. Global Viral Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Viral Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Viral Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Viral Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Viral Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global Viral Vaccines Revenue Market Share by Region (2024-2029)
Table 10. Global Viral Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Viral Vaccines Sales by Region (2018-2024) & (K MT)
Table 12. Global Viral Vaccines Sales by Region (2024-2029) & (K MT)
Table 13. Global Viral Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global Viral Vaccines Sales Market Share by Region (2024-2029)
Table 15. Global Viral Vaccines Sales by Manufacturers (2018-2024) & (K MT)
Table 16. Global Viral Vaccines Sales Share by Manufacturers (2018-2024)
Table 17. Global Viral Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Viral Vaccines Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Viral Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Viral Vaccines Price by Manufacturers 2018-2024 (USD/MT)
Table 21. Global Viral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Viral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vaccines as of 2022)
Table 23. Global Key Manufacturers of Viral Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Viral Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Viral Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Vaccines Sales by Type (2018-2024) & (K MT)
Table 28. Global Viral Vaccines Sales by Type (2024-2029) & (K MT)
Table 29. Global Viral Vaccines Sales Share by Type (2018-2024)
Table 30. Global Viral Vaccines Sales Share by Type (2024-2029)
Table 31. Global Viral Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Viral Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Viral Vaccines Revenue Share by Type (2018-2024)
Table 34. Global Viral Vaccines Revenue Share by Type (2024-2029)
Table 35. Viral Vaccines Price by Type (2018-2024) & (USD/MT)
Table 36. Global Viral Vaccines Price Forecast by Type (2024-2029) & (USD/MT)
Table 37. Global Viral Vaccines Sales by Application (2018-2024) & (K MT)
Table 38. Global Viral Vaccines Sales by Application (2024-2029) & (K MT)
Table 39. Global Viral Vaccines Sales Share by Application (2018-2024)
Table 40. Global Viral Vaccines Sales Share by Application (2024-2029)
Table 41. Global Viral Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Viral Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Viral Vaccines Revenue Share by Application (2018-2024)
Table 44. Global Viral Vaccines Revenue Share by Application (2024-2029)
Table 45. Viral Vaccines Price by Application (2018-2024) & (USD/MT)
Table 46. Global Viral Vaccines Price Forecast by Application (2024-2029) & (USD/MT)
Table 47. US & Canada Viral Vaccines Sales by Type (2018-2024) & (K MT)
Table 48. US & Canada Viral Vaccines Sales by Type (2024-2029) & (K MT)
Table 49. US & Canada Viral Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Viral Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Viral Vaccines Sales by Application (2018-2024) & (K MT)
Table 52. US & Canada Viral Vaccines Sales by Application (2024-2029) & (K MT)
Table 53. US & Canada Viral Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Viral Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Viral Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Viral Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Viral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Viral Vaccines Sales by Country (2018-2024) & (K MT)
Table 59. US & Canada Viral Vaccines Sales by Country (2024-2029) & (K MT)
Table 60. Europe Viral Vaccines Sales by Type (2018-2024) & (K MT)
Table 61. Europe Viral Vaccines Sales by Type (2024-2029) & (K MT)
Table 62. Europe Viral Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Viral Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Viral Vaccines Sales by Application (2018-2024) & (K MT)
Table 65. Europe Viral Vaccines Sales by Application (2024-2029) & (K MT)
Table 66. Europe Viral Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Viral Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Viral Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Viral Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Viral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Viral Vaccines Sales by Country (2018-2024) & (K MT)
Table 72. Europe Viral Vaccines Sales by Country (2024-2029) & (K MT)
Table 73. China Viral Vaccines Sales by Type (2018-2024) & (K MT)
Table 74. China Viral Vaccines Sales by Type (2024-2029) & (K MT)
Table 75. China Viral Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Viral Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Viral Vaccines Sales by Application (2018-2024) & (K MT)
Table 78. China Viral Vaccines Sales by Application (2024-2029) & (K MT)
Table 79. China Viral Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Viral Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Viral Vaccines Sales by Type (2018-2024) & (K MT)
Table 82. Asia Viral Vaccines Sales by Type (2024-2029) & (K MT)
Table 83. Asia Viral Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Viral Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Viral Vaccines Sales by Application (2018-2024) & (K MT)
Table 86. Asia Viral Vaccines Sales by Application (2024-2029) & (K MT)
Table 87. Asia Viral Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Viral Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Viral Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Viral Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Viral Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Viral Vaccines Sales by Region (2018-2024) & (K MT)
Table 93. Asia Viral Vaccines Sales by Region (2024-2029) & (K MT)
Table 94. Middle East, Africa and Latin America Viral Vaccines Sales by Type (2018-2024) & (K MT)
Table 95. Middle East, Africa and Latin America Viral Vaccines Sales by Type (2024-2029) & (K MT)
Table 96. Middle East, Africa and Latin America Viral Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Viral Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Viral Vaccines Sales by Application (2018-2024) & (K MT)
Table 99. Middle East, Africa and Latin America Viral Vaccines Sales by Application (2024-2029) & (K MT)
Table 100. Middle East, Africa and Latin America Viral Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Viral Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Viral Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Viral Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Viral Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Viral Vaccines Sales by Country (2018-2024) & (K MT)
Table 106. Middle East, Africa and Latin America Viral Vaccines Sales by Country (2024-2029) & (K MT)
Table 107. GSK Company Information
Table 108. GSK Description and Major Businesses
Table 109. GSK Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. GSK Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. GSK Recent Developments
Table 112. Merck Company Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Merck Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Novartis Company Information
Table 118. Novartis Description and Major Businesses
Table 119. Novartis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Novartis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Novartis Recent Developments
Table 122. Pfizer Company Information
Table 123. Pfizer Description and Major Businesses
Table 124. Pfizer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Pfizer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pfizer Recent Developments
Table 127. Sanofi Company Information
Table 128. Sanofi Description and Major Businesses
Table 129. Sanofi Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. Sanofi Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Sanofi Recent Developments
Table 132. Bayer Company Information
Table 133. Bayer Description and Major Businesses
Table 134. Bayer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Bayer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bayer Recent Developments
Table 137. Zoetis Company Information
Table 138. Zoetis Description and Major Businesses
Table 139. Zoetis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. Zoetis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Zoetis Recent Developments
Table 142. AstraZeneca Company Information
Table 143. AstraZeneca Description and Major Businesses
Table 144. AstraZeneca Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. AstraZeneca Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. AstraZeneca Recent Developments
Table 147. Johnson Company Information
Table 148. Johnson Description and Major Businesses
Table 149. Johnson Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 150. Johnson Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Johnson Recent Developments
Table 152. CSL Company Information
Table 153. CSL Description and Major Businesses
Table 154. CSL Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 155. CSL Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. CSL Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Viral Vaccines Distributors List
Table 160. Viral Vaccines Customers List
Table 161. Viral Vaccines Market Trends
Table 162. Viral Vaccines Market Drivers
Table 163. Viral Vaccines Market Challenges
Table 164. Viral Vaccines Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Vaccines Product Picture
Figure 2. Global Viral Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Viral Vaccines Market Share by Type in 2022 & 2029
Figure 4. Attenuated Vaccine Product Picture
Figure 5. Inactivated Vaccine Product Picture
Figure 6. Global Viral Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Viral Vaccines Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmaceutical Factory
Figure 10. Research Institute
Figure 11. Others
Figure 12. Viral Vaccines Report Years Considered
Figure 13. Global Viral Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Viral Vaccines Revenue 2018-2029 (US$ Million)
Figure 15. Global Viral Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Viral Vaccines Revenue Market Share by Region (2018-2029)
Figure 17. Global Viral Vaccines Sales 2018-2029 ((K MT)
Figure 18. Global Viral Vaccines Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Viral Vaccines Sales YoY (2018-2029) & (K MT)
Figure 20. US & Canada Viral Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Viral Vaccines Sales YoY (2018-2029) & (K MT)
Figure 22. Europe Viral Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Viral Vaccines Sales YoY (2018-2029) & (K MT)
Figure 24. China Viral Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Viral Vaccines Sales YoY (2018-2029) & (K MT)
Figure 26. Asia (excluding China) Viral Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Viral Vaccines Sales YoY (2018-2029) & (K MT)
Figure 28. Middle East, Africa and Latin America Viral Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Viral Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Viral Vaccines in the World: Market Share by Viral Vaccines Revenue in 2022
Figure 31. Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Viral Vaccines Sales Market Share by Type (2018-2029)
Figure 33. Global Viral Vaccines Revenue Market Share by Type (2018-2029)
Figure 34. Global Viral Vaccines Sales Market Share by Application (2018-2029)
Figure 35. Global Viral Vaccines Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Viral Vaccines Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Viral Vaccines Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Viral Vaccines Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Viral Vaccines Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Viral Vaccines Revenue Share by Country (2018-2029)
Figure 41. US & Canada Viral Vaccines Sales Share by Country (2018-2029)
Figure 42. U.S. Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Viral Vaccines Sales Market Share by Type (2018-2029)
Figure 45. Europe Viral Vaccines Revenue Market Share by Type (2018-2029)
Figure 46. Europe Viral Vaccines Sales Market Share by Application (2018-2029)
Figure 47. Europe Viral Vaccines Revenue Market Share by Application (2018-2029)
Figure 48. Europe Viral Vaccines Revenue Share by Country (2018-2029)
Figure 49. Europe Viral Vaccines Sales Share by Country (2018-2029)
Figure 50. Germany Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 51. France Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 55. China Viral Vaccines Sales Market Share by Type (2018-2029)
Figure 56. China Viral Vaccines Revenue Market Share by Type (2018-2029)
Figure 57. China Viral Vaccines Sales Market Share by Application (2018-2029)
Figure 58. China Viral Vaccines Revenue Market Share by Application (2018-2029)
Figure 59. Asia Viral Vaccines Sales Market Share by Type (2018-2029)
Figure 60. Asia Viral Vaccines Revenue Market Share by Type (2018-2029)
Figure 61. Asia Viral Vaccines Sales Market Share by Application (2018-2029)
Figure 62. Asia Viral Vaccines Revenue Market Share by Application (2018-2029)
Figure 63. Asia Viral Vaccines Revenue Share by Region (2018-2029)
Figure 64. Asia Viral Vaccines Sales Share by Region (2018-2029)
Figure 65. Japan Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 69. India Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Viral Vaccines Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Viral Vaccines Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Viral Vaccines Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Viral Vaccines Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Viral Vaccines Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Viral Vaccines Sales Share by Country (2018-2029)
Figure 76. Brazil Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Viral Vaccines Revenue (2018-2029) & (US$ Million)
Figure 81. Viral Vaccines Value Chain
Figure 82. Viral Vaccines Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries